NT-proBNP levels improved CVD risk prediction in women

N-terminal pro–B-type natriuretic peptide modestly improved measures of CVD risk prediction in women with numerous CV events, according to new data published in the Journal of the American College of Cardiology.The addition of NT-proBNP levels to traditional risk factors and Reynolds Risk Score covariables also led to a small but significant improvement in CVD risk prediction.

Follow us